tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IONS Stock Latest News

Ionis Pharmaceuticals price target raised to $49 from $48 at JPMorgan
The FlyIonis Pharmaceuticals price target raised to $49 from $48 at JPMorgan
8h ago
IONS
Ionis Pharmaceuticals: Buy Rating Driven by Anticipated Phase 3 Trial Results for Olezarsen
PremiumRatings
Ionis Pharmaceuticals: Buy Rating Driven by Anticipated Phase 3 Trial Results for Olezarsen
9h ago
IONS
Ionis Pharmaceuticals: Hold Rating Amidst Competitive Challenges and Pricing Uncertainties
PremiumRatings
Ionis Pharmaceuticals: Hold Rating Amidst Competitive Challenges and Pricing Uncertainties
3d ago
IONS
Ionis Pharmaceuticals’ Strategic Advantage in the HAE Market with DAWNZERA Approval
PremiumRatings
Ionis Pharmaceuticals’ Strategic Advantage in the HAE Market with DAWNZERA Approval
3d ago
IONS
Ionis Pharmaceuticals price target raised to $70 from $65 at H.C. Wainwright
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $70 from $65 at H.C. Wainwright
3d ago
TAK
IONS
Ionis Pharmaceuticals price target raised to $65 from $62 at Piper Sandler
PremiumThe FlyIonis Pharmaceuticals price target raised to $65 from $62 at Piper Sandler
3d ago
IONS
Ionis Pharmaceuticals price target raised to $69 from $65 at Citi
Premium
The Fly
Ionis Pharmaceuticals price target raised to $69 from $65 at Citi
3d ago
IONS
Ionis Pharmaceuticals price target raised to $82 from $77 at Wells Fargo
Premium
The Fly
Ionis Pharmaceuticals price target raised to $82 from $77 at Wells Fargo
3d ago
IONS
Ionis Pharmaceuticals price target raised to $58 from $57 at Barclays
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $58 from $57 at Barclays
3d ago
IONS
Ionis Pharmaceuticals price target raised to $64 from $63 at BofA
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $64 from $63 at BofA
4d ago
IONS
Ionis Pharmaceuticals’ Dawnzera: A Promising New Entrant in HAE Treatment with Strong Market Potential
PremiumRatings
Ionis Pharmaceuticals’ Dawnzera: A Promising New Entrant in HAE Treatment with Strong Market Potential
4d ago
IONS
Ionis Pharmaceuticals: Strategic Positioning and Revenue Potential Boost Buy Rating
PremiumRatings
Ionis Pharmaceuticals: Strategic Positioning and Revenue Potential Boost Buy Rating
4d ago
IONS
Ionis Pharmaceuticals price target raised to $43 from $38 at Stifel
PremiumThe FlyIonis Pharmaceuticals price target raised to $43 from $38 at Stifel
4d ago
IONS
Ionis Pharmaceuticals Gains FDA Approval for DAWNZERA
Premium
Company Announcements
Ionis Pharmaceuticals Gains FDA Approval for DAWNZERA
4d ago
8K
IONS
Ionis Pharmaceuticals trading resumes
Premium
The Fly
Ionis Pharmaceuticals trading resumes
4d ago
IONS
Ionis Pharmaceuticals announces FDA approval of Dawnzera
PremiumThe Fly
Ionis Pharmaceuticals announces FDA approval of Dawnzera
4d ago
IONS
Ionis Pharmaceuticals trading halted, news pending
PremiumThe Fly
Ionis Pharmaceuticals trading halted, news pending
4d ago
IONS
Promising Prospects for Ionis Pharmaceuticals: Buy Rating Backed by Olezarsen’s Potential in sHTG Market
PremiumRatings
Promising Prospects for Ionis Pharmaceuticals: Buy Rating Backed by Olezarsen’s Potential in sHTG Market
6d ago
IONS
Ionis Pharmaceuticals price target raised to $46 from $45 at UBS
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $46 from $45 at UBS
13d ago
IONS
Positive Outlook for Ionis Pharmaceuticals Driven by Strong Q2 Results and Promising Pipeline Developments
PremiumRatingsPositive Outlook for Ionis Pharmaceuticals Driven by Strong Q2 Results and Promising Pipeline Developments
24d ago
IONS
Ionis Pharmaceuticals Reports Strong Earnings and Growth
Premium
Company Announcements
Ionis Pharmaceuticals Reports Strong Earnings and Growth
25d ago
IONS
Ionis Pharmaceuticals: Hold Rating Amid Strong Performance and Future Uncertainties
Premium
Ratings
Ionis Pharmaceuticals: Hold Rating Amid Strong Performance and Future Uncertainties
25d ago
IONS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >